Position in ARVN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,034,861
+$2,099,603 QoQ
Shares Held
365,206
+313.9% QoQ
Ownership
0.559%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. ARVN ranks #185 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,034,861 | 365,206 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $935,258 | 88,232 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $223,014 | 18,804 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $85,156 | 9,995 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $65,003 | 8,832 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,485,345 | 496,488 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $29,882,711 | 1,558,827 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $71,023,165 | 2,883,604 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $71,322,618 | 2,679,287 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $98,616,019 | 2,388,954 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $92,363,820 | 2,244,019 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $95,613,312 | 4,868,295 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $109,248,406 | 4,401,628 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $156,216,605 | 5,718,031 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $193,610,467 | 5,659,470 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $298,210,817 | 6,702,873 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $309,916,792 | 7,363,193 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $484,277,539 | 7,195,803 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $571,829,765 | 6,961,648 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $579,640,684 | 7,053,306 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $460,682,145 | 5,982,885 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $280,912,571 | 4,249,812 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $432,296,926 | 5,090,038 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $105,800,753 | 4,481,184 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $128,272,454 | 3,824,462 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $108,886,528 | 2,701,899 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||